The Benefits of High Relaxivity for Brain Tumor Imaging: Results of a Multicenter Intraindividual Crossover Comparison of Gadobenate Dimeglumine with Gadoterate Meglumine (The BENEFIT Study)

Cesare Colosimo, M. Vaneckova, M. Herman, M. P. Smith, M. Mechl, K. R. Maravilla, J. Weichet, M. V. Spampinato, J. Žižka, F. J. Wippold, J. J. Baima, R. Babbel, E. Bültmann, R. Y. Huang, J. H. Buhk, A. Bonafé, S. Lui, M. A. Kirchin, N. Shen, G. PirovanoA. Spinazzi

Risultato della ricerca: Contributo in rivistaArticolo in rivista

19 Citazioni (Scopus)

Abstract

Gadobenate dimeglumine (MultiHance) has higher r1 relaxivity than gadoterate meglumine (Dotarem) which may permit the use of lower doses for MR imaging applications. Our aim was to compare 0.1- and 0.05-mmol/kg body weight gadobenate with 0.1-mmol/kg body weight gadoterate for MR imaging assessment of brain tumors.
Lingua originaleEnglish
pagine (da-a)1589-1598
Numero di pagine10
RivistaAJNR, AMERICAN JOURNAL OF NEURORADIOLOGY
Volume36
DOI
Stato di pubblicazionePubblicato - 2015

Keywords

  • Benefits
  • Brain Tumor Imaging
  • Gadoterate Meglumine
  • High Relaxivity
  • The BENEFIT Study

Fingerprint

Entra nei temi di ricerca di 'The Benefits of High Relaxivity for Brain Tumor Imaging: Results of a Multicenter Intraindividual Crossover Comparison of Gadobenate Dimeglumine with Gadoterate Meglumine (The BENEFIT Study)'. Insieme formano una fingerprint unica.

Cita questo